SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 390 filers reported holding SEATTLE GENETICS INC in Q1 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $28,084,000 | -29.2% | 143,517 | -38.5% | 0.02% | -39.3% |
Q2 2020 | $39,645,000 | +164.2% | 233,325 | +79.4% | 0.03% | +115.4% |
Q1 2020 | $15,004,000 | -18.4% | 130,046 | -19.2% | 0.01% | 0.0% |
Q4 2019 | $18,384,000 | +81.8% | 160,897 | +35.9% | 0.01% | +44.4% |
Q3 2019 | $10,111,000 | +40.5% | 118,395 | +13.9% | 0.01% | +50.0% |
Q2 2019 | $7,199,000 | +7.6% | 103,992 | +13.9% | 0.01% | 0.0% |
Q1 2019 | $6,690,000 | +9.7% | 91,340 | -15.1% | 0.01% | 0.0% |
Q4 2018 | $6,096,000 | -28.1% | 107,574 | -2.1% | 0.01% | -25.0% |
Q3 2018 | $8,477,000 | +9.4% | 109,932 | -5.8% | 0.01% | 0.0% |
Q2 2018 | $7,748,000 | +28.2% | 116,730 | +1.1% | 0.01% | +33.3% |
Q1 2018 | $6,044,000 | -16.1% | 115,478 | -14.2% | 0.01% | 0.0% |
Q4 2017 | $7,202,000 | -47.2% | 134,621 | -46.3% | 0.01% | -53.8% |
Q3 2017 | $13,639,000 | -8.2% | 250,677 | -12.7% | 0.01% | -7.1% |
Q2 2017 | $14,858,000 | -30.5% | 287,164 | -15.5% | 0.01% | -26.3% |
Q1 2017 | $21,364,000 | +54.5% | 339,842 | +29.7% | 0.02% | +35.7% |
Q4 2016 | $13,832,000 | -23.3% | 262,106 | -21.5% | 0.01% | -17.6% |
Q3 2016 | $18,033,000 | +56.5% | 333,874 | +17.1% | 0.02% | +30.8% |
Q2 2016 | $11,524,000 | -0.2% | 285,131 | -13.3% | 0.01% | -7.1% |
Q1 2016 | $11,543,000 | +0.1% | 328,987 | +28.0% | 0.01% | +7.7% |
Q4 2015 | $11,534,000 | +9.6% | 257,017 | -5.8% | 0.01% | 0.0% |
Q3 2015 | $10,523,000 | -32.7% | 272,914 | -15.6% | 0.01% | -13.3% |
Q2 2015 | $15,647,000 | +57.9% | 323,293 | +15.3% | 0.02% | +50.0% |
Q1 2015 | $9,908,000 | +9.2% | 280,307 | -0.7% | 0.01% | +25.0% |
Q4 2014 | $9,071,000 | +7.3% | 282,337 | +24.2% | 0.01% | +14.3% |
Q3 2014 | $8,454,000 | -5.1% | 227,372 | -2.4% | 0.01% | 0.0% |
Q2 2014 | $8,911,000 | +21.1% | 232,926 | +44.2% | 0.01% | 0.0% |
Q1 2014 | $7,360,000 | +1.3% | 161,556 | -11.3% | 0.01% | 0.0% |
Q4 2013 | $7,265,000 | -1.3% | 182,132 | +8.4% | 0.01% | 0.0% |
Q3 2013 | $7,364,000 | -11.4% | 168,010 | -36.4% | 0.01% | -12.5% |
Q2 2013 | $8,310,000 | +49.4% | 264,160 | +68.7% | 0.01% | +33.3% |
Q1 2013 | $5,561,000 | – | 156,623 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 51,049,760 | $3,738,884,000 | 23.93% |
Lagoda Investment Management, L.P. | 76,873 | $5,630,000 | 7.16% |
Matrix Capital Management Company, LP | 3,141,852 | $230,109,000 | 6.14% |
DOMINI IMPACT INVESTMENTS LLC | 3,120 | $229,000 | 3.51% |
Opus Point Partners Management, LLC | 17,832 | $1,306,000 | 1.77% |
Capital International Sarl | 188,200 | $13,784,000 | 1.72% |
EMORY UNIVERSITY | 33,368 | $2,444,000 | 1.72% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,460,000 | 1.65% |
CAPITAL GUARDIAN TRUST CO | 1,358,254 | $99,415,000 | 1.32% |
Rhenman & Partners Asset Management AB | 150,598 | $11,030,000 | 1.29% |